Competition Winners

• TRIM-Line, Marc Carrier, MD, MSc (Top Prize)
• HIPSTER, Federico Germini, MD, MSc, PhD (Runner-up)

• BAT-VTE, Laurent Bertoletti, MD, PhD (Top Prize)
• PROSPECT, Madhvi Rajpurkar, MD (Runner-up)

• CONQUER-DVT, Nicole Potere, MD (Top-Prize)
• COBRRA, Lana Castelluci, MD, MSc (Runner-up)

• SAVER, Aurélien Delluc, MD, PhD / Francis Couturaud, MD, PhD (Top-Prize)
• API-CALF, Jean-Philippe Galanaud, MD, PhD (Runner-up)

SAFE-SSPE, Christine Baumgartner, MD, PhD.

The funding to permit the study to be expanded into in France through the INNOVTE Network, the Netherlands through the Dutch Thrombosis Network, and Canada through the CanVECTOR Network.

Pilot PARTUM, Leslie Skeith, Md, MSc.

The funding to permit the trial to be expand into the U.S.A through the VENUS Network and the Netherlands through the Dutch Thrombosis Network.

No competitions held this calendar year.

• START Pilot, Tzu-Fei Wang, MD, MSc 

• DAA in Cancer, Rushad Patell, MD
• PEITHO-3, Olivier Sanchez, MD
• PREP and GO, Leslie Skeith, MD, MSc
• API-CALF, Jean-Philippe Galanaud, MD, PhD
• HYPATIA, Leslie Skeith, MD, MSc

• API-CALF, Jean-Philippe Galanaud, MD, PhD 
• SAVER, Stavros Konstantinides, MD, PhD
• SPECTACULAR, Grégoire Le Gal, Md, PhD

• Dr. Frederikus Klok of the Dutch Thrombosis Network Network has been awarded $20,000 (CAD) to facilitate the expansion of the RHEA study in the TRIP Network in collaboration with Prof. Walter Ageno at Varese University Hospital in Varese, Italy. RHEA is a prospective study to evaluate the diagnostic accuracy of MRDTI (Magnetic resonance direct thrombus imaging )for acute and chronic splanchnic vein thrombosis and to assess interobserver agreement of expert readers.
• Prof. Saskia Middeldorp of the Dutch Thrombosis Network Network has been awarded $20,000 (CAD) to facilitate the development of three new recruitment sites for the MEDEA Study in the INViTE Network in collaboration with Prof. Fionnuala Ní Áinle.  MEDEA is a randomized controlled trial assessing heavy menstrual bleeding in premenopausal women treated with direct oral anticoagulants. 

• Dr. M. Di Nisio of the TRIP Network has been awarded $15,000 to open the in the Dutch Thrombosis Network in collaboration with Dr. Floris T.M. Bosch at the Amsterdam University Medical Center. REDUCE is a prospective cohort study assessing the Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients.
• Dr. Grégoire Le Gal of the CanVECTOR Network has been awarded $15,000 to open ADJUST-DVT in the INNOVTE Network in collaboration with Dr. Moustafa Fares at the CHU Gabriel-Montpied, Pôle Urgences. ADJUST-DVT is a prospective outcome study assessing an Age-adjusted D-dimer cut-off levels to rule out deep vein thrombosis.
• Dr.Lana Castellucci of the CanVECTOR Network has been awarded $15,000 to open the COBRRA trial in the THANZ Network in collaboration Dr. Vivien Chen at the Concord Hospital in Sydney Australia. COBRRA  is a Phase 4 multicentre RCT assessing the Comparison of bleeding Risk between Rivaroxaban and Apixaban.

 Bipin Paruchuri, PhD (U.S.A.)

• Current position: Post-doctoral research associate, Case Western Reserve University, Cleveland, USA
• Topic: Intravital Assessment of Bioresponsive Hemostatic Nanotherapeutics
• Host Institute / Department: Department of Internal Medicine I, Ludwig-Maximilians-University of Munich, Germany
• Supervisor: Dr. Leo Nicolai, MD

Elena Butera, MD (Italy)

• Current position: Internal Medicine Resident, Università Cattolica del Sacro Cuore, Rome Italy
• Topic: Exploring Growth Differentiation Factor 15 (GDF-15) as a biomarker and investigating genetic polymorphisms in genes involved in coagulation and fibrinolytic systems for predicting postoperative bleeding in PERIOP-01 patients.
• Host Institute / Department: Ottawa Hospital Research Institute / The Ottawa Hospital, Ottawa, Canada.
• Supervisor: Marc Carrier, MD, MSc, FRCPC

Aaron Iding, MD (The Netherlands)

• Current position: PhD Candidate / Clinical Thrombosis & Hemostasis, Maastricht University Medical Center, Maastricht, Netherlands
• Topic: Untangling classes of post-thrombotic syndrome using unsupervised machine learning: A post hoc analysis of the IDEAL trial
• Host Institute / Department: Department of Clinical Epidemiology & Systems Medicine, Johannes Guttenberg University of Mainz, Germany
• Supervisor: Philipp Wild, MD, MSc

Jad el Maamari, MD (Canada)

• Current position: Clinical specialty fellow, BC Children's Hospital / University of British Columbia, Vancouver, Canada
• Topic: Normative coagulation in children - a mutli analyser comparison (in conjunction wth the larger overall Happikids Study)
• Host Institute / Department: Department of Pediatrics, Royal Children's Hospital / The University of Melbourne, Melbourne, Australia 
• Supervisor: Paul Monagle, MBBS MD MSc

Sarah Kelliher, MD (Ireland)

• Current position: PhD candidate/Haematology, University College Dublin/Mater Misericordiae University Hospital
• Research topic: Defining the Prothrombotic Platelet Phenotype in MPN: A Cross-Institutional Multi-omic Collaborative
• Fellowship Location: Department of Pathology, School of Medicine, Stanford University
• Supervisor: Anandi Krishnan, PhD

Vicky Mai, MD (Canada)

• Current position: Thrombosis Research Fellow,  University of Ottawa/Ottawa Hospital
• Research topic: Management of Patients with Suspicion of PE Amongst Patients with COPDe
• Fellowship Location:Western Brittany Thrombosis Research Group,  Centre Hospitalier Régional et Universitaire (CHRU) de Brest
• Supervisor: Francis Couturaud, MD, PhD

Jenneke Leentjens, M.D., Ph.D. (the Netherlands)

Maria Rita Peralta, M.D. (U.K.)

Nicola Potere, M.D. (Italy)